Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte D'Ivoire

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue 1, 2003, Pages 37-51

  N'Goran, E K ^a,b   Gnaka, H N ^c   Tanner, M ^d   Utzinger, J ^e  

^a UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^b CENTRE SUISSE DE RECHERCHES SCIENTIFIQUES EN CÔTE D'IVOIRE   (Côte d’Ivoire)

^c Grandes Endemies de Tiassale ^*  (Côte d’Ivoire)

^d SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^e PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; COTE D'IVOIRE; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARASITE IDENTIFICATION; PRURITUS; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; URINALYSIS; VERTIGO; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COTE D'IVOIRE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; PARASITE EGG COUNT; PRAZIQUANTEL; SCHISTOSOMIASIS HAEMATOBIA;

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; TREMATODA;

EID: 0037285950     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803125002553     Document Type: Article

References (51)

1. Appleton, C. C. & Mbaye, A. (2001). Praziquantel - quality, dosages and markers of resistance. Trends in Parasitology, 17, 356-357.
2. Bergquist, N. R. (2002). Schistosomiasis: from risk assessment to control. Trends in Parasitology, 18, 309-314.
3. Berhe, N., Gundersen, S. G., Abebe, F., Birrie, H., Medhin, G. & Gemetchu, T. (1999). Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia. Acta Tropica, 72, 53-63.
4. Borrmann, S., Szlezák, N., Faucher, J.-F., Matsiegui, P.-B., Neubauer, R., Binder, R. K., Lell, B. & Kremsner, P. G. (2001). Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. Journal of Infectious Diseases, 184, 1363-1366.
5. Cioli, D. (1998). Chemotherapy of schistosomiasis: an update. Parasitology Today, 14, 418-422.
6. Cioli, D. (2000). Praziquantel: is there real resistance and are there alternatives? Current Opinion in Infectious Diseases, 13, 659-663.
7. Cioli, D., Pica-Mattoccia, L. & Archer, S. (1995). Antischistosomal drugs: past, present ... and future? Pharmacology and Therapeutics, 68, 35-85.
8. Danso-Appiah, A. & de Vlas, S. J. (2002). Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends in Parasitology, 18, 125-129.
9. Davis, A. & Wegner, D. H. (1979). Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bulletin of the World Health Organization, 57, 767-771.
10. De Clercq, D., Vercruysse, J., Verlé, P., Kongs, A. & Diop, M. (2000). What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? Tropical Medicine and International Health, 5, 744-746.
11. De Clercq, D., Vercruysse, J., Kongs, A., Verlé, P., Dompnier, J. P. & Faye, P. C. (2002). Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Tropica, 82, 61-66.
12. Doenhoff, M., Kimani, G. & Cioli, D. (2000). Praziquantel and the control of schistosomiasis. Parasitology Today, 16, 364-366.
13. Engels, D., Chitsulo, L., Montresor, A. & Savioli, L. (2002). The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica, 82, 139-146.
14. Garba, A., Tohon, Z., Sidiki, A., Chippaux, J.-P. & de Chabalier, F. (2001). Efficacité et tolérance du praziquantel chez l'enfant d'âge scolaire en zone hyper-endémique à Schistosoma haematobium (Niger, 1999). Bulletin de la Société de Pathologie Exotique, 94, 42-45.
15. Gönnert, R. & Andrews, P. (1977). Praziquantel, a new broad-spectrum antischistosomal agent. Zeitschrift für Parasitenkunde, 52, 129-150.
16. Groll, E. (1984). Praziquantel. Advances in Pharmacology and Chemotherapy, 20, 219-238.
17. Gryseels, B., Mbaye, A., De Vlas, S. J., Stelma, F. F., Guissé, F., van Lieshout, L., Faye, D., Diop, M., Ly, A., Tchuem-Tchuenté, L. A., Engels, D. & Polman, K. (2001). Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health, 6, 864-873.
18. Guissé, F., Polman, K., Stelma, F. F., Mbaye, A., Talla, I., Niang, M., Deelder, A. M., Ndir, O. & Gryseels, B. (1997). Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal. American Journal of Tropical Medicine and Hygiene, 56, 511-514.
19. Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L. F. & Bennett, J. L. (1996). Characterisation of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. American Journal of Tropical Medicine and Hygiene, 55, 214-218.
20. Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L. F., Day, T. A. & Bennett, J. L. (1999). Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. American Journal of Tropical Medicine and Hygiene, 60, 932-935.
21. James, C., Webbe, G. & Nelson, G. S. (1977). The susceptibility to praziquantel of Schistosoma haematobium in the baboon (Papio anubis) and of S. japonicum in the vervet monkey (Cercopithecus aethiops). Zeitschrift für Parasitenkunde, 52, 179-194.
22. Kahama, A. I., Vennervald, B. J., Kombe, Y., Kihara, R. W., Ndzovu, M., Mungai, P. & Ouma, J. H. (1999). Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the Coast province of Kenya. Tropical Medicine and International Health, 4, 335-340.
23. King, C. H., Muchiri, E. M. & Ouma, J. H. (2000). Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerging Infectious Diseases, 6, 585-594.
24. Kusel, J. & Hagan, P. (1999). Praziquantel - its use, cost and possible development of resistance. Parasitology Today, 15, 352-354.
25. Massoud, A. A. E., El Kholy, A. M. & Anwar, W. A. (1984). Assessment of efficacy of praziquantel against Schistosoma mansoni infection. Journal of Tropical Medicine and Hygiene, 87, 119-121.
26. N'Goran, E. K., Diabate, S., Utzinger, J. & Sellin, B. (1997). Changes in human schistosomiasis levels after the construction of two large hydroelectric dams in central Côte d'Ivoire. Bulletin of the World Health Organization, 75, 541-545.
27. N'Goran, E. K., Utzinger, J., N'Guessan, A. N., Müller, I., Zamblé, K., Lohourignon, K. L., Traoré, M., Sosthène, B. A., Lengeler, C. & Tanner, M. (2001). Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d'Ivoire. Tropical Medicine and International Health, 6, 817-825.
28. N'Goran, E. K., Utzinger, J., Gnaka, H. N., Yapi, A., N'Guessan, N. A., Kigbafori, S. D., Lengeler, C., Chollet, J., Xiao, S. H. & Tanner, M. (2003). Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. American Journal of Tropical Medicine and Hygiene, 68, 24-32.
29. Ofoezie, I. E. (2000). Patterns of reinfection following praziquantel treatment of urinary schistosomiasis at a period of low transmission. Acta Tropica, 75, 123-126.
30. Olds, G. R., King, C., Hewlett, J., Olveda, R., Wu, G., Ouma, J., Peters, P., McGarvey, S., Odhiambo, O., Koech, D., Liu, C. Y., Aligui, G., Gachihi, G., Kombe, Y., Parraga, I., Ramirez, B., Whalen, C., Horton, R. J. & Reeve, P. (1999). Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. Journal of Infectious Diseases, 179, 996-1003.
31. Picquet, M., Vercruysse, J., Shaw, D. J., Diop, M. & Ly, A. (1998). Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 90-93.
32. Plouvier, S., Leroy, J.-C. & Colette, J. (1975). A propos d'une technique simple de filtration des urines dans le diagnostic de la bilharziose urinaire en enquête de masse. Médecine Tropicale, 35, 229-230.
33. Renganathan, E. & Cioli, D. (1998). An international initiative on praziquantel use. Parasitology Today, 14, 390-391.
34. Sabah, A. A., Fletcher, C., Webbe, G. & Doenhoff, M. J. (1986). Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology, 61, 294-303.
35. Seubert, J., Pohlke, R. & Loebich, F. (1977). Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia, 33, 1036-1037.
36. Shaw, D. J., Vercruysse, J., Picquet, M., Sambou, B. & Ly, A. (1999). The effect of different treatment regimens on the epidemiology of seasonally transmitted Schistosoma haematobium infections in four villages in the Senegal River Basin, Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 142-150.
37. Stelma, F. F., Sall, S., Daff, B., Sow, S., Niang, M. & Gryseels, B. (1997). Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. Journal of Infectious Diseases, 176, 304-307.
38. Thomas, H. & Gönnert, R. (1977). The efficacy of praziquantel against cestodes in animals. Zeitschrift für Parasitenkunde, 52, 117-127.
39. Utzinger, J., N'Goran, E. K., N'Dri, A., Lengeler, C. & Tanner, M. (2000). Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Tropical Medicine and International Health, 5, 771-778.
40. Utzinger, J., Chollet, J., You, J. Q., Mei, J. Y., Tanner, M. & Xiao, S. H. (2001a). Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Tropica, 80, 9-18.
41. Utzinger, J., Xiao, S. H., N'Goran, E. K., Bergquist, R. & Tanner, M. (2001b). The potential of artemether for the control of schistosomiasis. International Journal for Parasitology, 31, 1549-1562.
42. Van Etten, L., Kremsner, P. G., Krijger, F. W. & Deelder, A. M. (1997). Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy. American Journal of Tropical Medicine and Hygiene, 57, 337-341.
43. Van Lieshout, L., Stelma, F. F., Guissé, F., Falcao Ferreira, S. T., Polman, K., van Dam, G. J., Diakhate, M., Sow, S., Deelder, A. & Gryseels, B. (1999). The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal. American Journal of Tropical Medicine and Hygiene, 61, 760-765.
44. Webbe, G. & James, C. (1977). A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters. Zeitschrift für Parasitenkunde, 52, 169-177.
45. Wegner, D. H. G. (1984). The profile of the trematodicidal compound praziquantel. Arzneimittelforschung, 34, 1132-1136.
46. William, S., Botros, S., Ismail, M., Farghally, A., Day, T. A. & Bennett, J. L. (2001a). Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology, 122, 63-66.
47. William, S., Sabra, A., Ramzy, F., Mousa, M., Demerdash, Z., Bennett, J. L., Day, T. A. & Botros, S. (2001b). Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. International Journal for Parasitology, 31, 1093-1100.
48. Wilkins, H. A. & Moore, P. J. (1987). Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia. Journal of Tropical Medicine and Hygiene, 90, 83-92.
49. Xiao, S. H., Catto, B. A. & Webster, L. T. (1985). Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Diseases, 151, 1130-1137.
50. Xiao, S. H., Utzinger, J., Chollet, J., Endriss, Y., N'Goran, E. K. & Tanner, M. (2000). Effect of artemether against Schistosoma haematobium in experimentally infected hamsters. International Journal for Parasitology, 30, 1001-1006.
51. Xiao, S. H., Tanner, M., N'Goran, E. K., Utzinger, J., Chollet, J., Bergquist, R., Chen, M. G. & Zeng, J. (2002). Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Tropica, 82, 175-181.